# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther King Jr. (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML001-SYN
- Date: 2026-09-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cornelius Ashby-Nwankwo, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Twenty-three-week review: remission, smoking, blood pressure and lipids. **S**

## History of present illness

Dr. King returns six weeks after a bronchitis, which settled in about two weeks without an antibiotic; he did not smoke through it. He has been smoke-free since the June lapse and is five weeks into the second course of varenicline. His mood has been good for over a month, he sleeps about seven hours, and therapy is now monthly. He has kept most of his work plan, though the autumn schedule is heavier. Home readings averaged 128/82. He has lost about a kilogram. He has no thoughts of harming himself. **S**

| Element | Detail |
|---|---|
| Bronchitis | Settled in about two weeks; no smoking |
| Smoking | Smoke-free since June; second varenicline course |
| Mood | Good; PHQ-9 4 |
| Home blood pressure | Average 128/82 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good |
| Respiratory | Negative | No cough |
| Cardiovascular | Negative | Scar aching rare; no chest pain on exertion |
| Psychiatric | Negative | Mood good; sleep seven hours; no suicidal ideation |

4 systems reviewed. **S**

## Current medications

- Varenicline 1 mg tablet, one by mouth twice daily after food **S**
- Sertraline 50 mg tablet, one by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/82 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 82.8 kg; BMI 28.7 kg/m². All vital signs are synthetic.

PHQ-9: 4; Total cholesterol: 196 mg/dL; Triglycerides: 120 mg/dL; HDL cholesterol: 45 mg/dL; LDL cholesterol (calculated): 127 mg/dL. All results are synthetic.

## Change since baseline

- PHQ-9: 17 at baseline, 4 at this visit **S**
- Total cholesterol: 214 mg/dL (high) at baseline, 196 mg/dL at this visit **S**
- Triglycerides: 150 mg/dL (high) at baseline, 120 mg/dL at this visit **S**
- HDL cholesterol: 42 mg/dL at baseline, 45 mg/dL at this visit **S**
- LDL cholesterol (calculated): 142 mg/dL (high) at baseline, 127 mg/dL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Blood pressure 128/82, pulse 70; weight 82.8 kg, BMI 28.7 |
| Respiratory | Clear |
| Psychiatric | Euthymic; no suicidal ideation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Major depressive disorder, in remission** (F32.1). PHQ-9 4, from 17: remission. **S**
   - Continue sertraline 50 mg for at least six to nine months after remission, then discuss a slow taper.
   - Monthly therapy; a relapse plan for heavy seasons and new threats.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed.
2. **Stage 1 hypertension, improving** (I10). Home average 128/82, at goal on the systolic and just above on the diastolic, without medicine. **S**
   - Continue lifestyle treatment; home readings monthly; review in three months.
3. **Lipids**. Total cholesterol 196, triglycerides 120, HDL 45 and calculated LDL 127 mg/dL, improved from an LDL of 142. With low estimated risk at 36 and LDL below 190 mg/dL, a statin is not indicated under the 2018 AHA/ACC guideline. **S**
   - Continue the diet and walking; lipids again in a year.
4. **Nicotine dependence, in early remission** (F17.210). Smoke-free since June. **S**
   - Finish the second twelve weeks of varenicline.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 4, from 17: remission |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation since the last visit; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed doses of sertraline or varenicline; no side effects |
| Self-management | Smoking status after the quit date | Every visit | Completed today | Smoke-free since June, including through the bronchitis |
| Survey | Insomnia Severity Index and sleep diary | Every visit during CBT for insomnia | Completed today | Insomnia Severity Index 7; about seven hours a night (score in the notes; no LOINC code used) |
| Examination | Home blood pressure readings | A week before each visit while treatment is adjusted | Completed today | Seven-day average 128/82 |
| Examination | Office blood pressure, weight and BMI | Every visit | Completed today | 128/82 mmHg; weight 82.8 kg, BMI 28.7 |
| Laboratory | Lipid panel | At diagnosis of hypertension; repeat after lifestyle change; then yearly | Completed today | LDL 127 mg/dL, HDL 45 mg/dL, triglycerides 120 mg/dL |
| Laboratory | Basic metabolic panel and urine albumin | Yearly when not on blood pressure medicine | Up to date | Normal at intake and at eight weeks |
| Self-management | Sustainable work plan: a day off each week, two speeches a day at most, sleep window kept | Every visit | Completed today | Kept on most weeks; heavier autumn schedule discussed |

## Goal progress

- Depression remission (PHQ-9 below 5) by six months. Outcome by 2026-09-15: PHQ-9 4 at twenty-three weeks, from 17. **S**
- Sleep of at least six and a half hours on most nights, with an Insomnia Severity Index below 10. Outcome by 2026-09-15: About seven hours on most nights; ISI 7 at twenty-three weeks. **S**
- Smoke-free, confirmed at every visit after the quit date. In progress; target 2026-11-30. **S**
- Home blood pressure below 130/80 mmHg with lifestyle changes. In progress; target 2026-12-31. **S**
- A sustainable schedule: one full day a week without work, no more than two speeches a day, and a two-week break in the summer. Outcome by 2026-07-14: Kept for six weeks; two-week break taken in July. **S**

## Guideline basis

- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017), American College of Cardiology and American Heart Association (Whelton PK, et al. Hypertension 2018;71(6):e13-e115)
- 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (2018), American Heart Association and American College of Cardiology (Grundy SM, et al. Circulation 2019;139(25):e1082-e1143)

## Follow-up

- Review in three months. Therapy monthly. **S**

